Godrej Agrovet Q4 Review - Robust Performance; Sustenance Will Be Key: Motilal Oswal
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Godrej Agrovet Ltd.’s strong Q4 FY21 performance was aided by all segments and low base of Q4 FY20.
Ebitda margin expanded 440 basis point YoY due to lower raw material costs (down 340 basis point YoY), which led to an Ebitda growth of 133%.
All segments reported a margin expansion, led by animal feed and standalone crop protection.
We have maintained the same for FY22E/FY23E as its Q4 FY21 performance was in line with our estimates.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.